EMSLR and urinary bladder carcinoma: In line with the findings observed from the populations, compared with BCCE4[G], BCCE4[A] substantially inhibited bladder cancer cell proliferation, migration and invasion in in vitro and in vivo studies, suggesting that BCCE4[A] ultimately contributes to inhibiting bladder cancer progression.